Immunothrombosis, or the interaction between immune responses and coagulation, contributes to cardiovascular disease by promoting microvascular thrombosis, inflammation, and endothelial dysfunction. Despite the widespread use of antiplatelet drugs, which target only some of the mechanisms involved, this
Immunothrombosis, or the interaction between immune responses and coagulation, contributes to cardiovascular disease by promoting microvascular thrombosis, inflammation, and endothelial dysfunction. Despite the widespread use of antiplatelet drugs, which target only some of the mechanisms involved, this